FDA Approved: LIRAGLUTIDE — Original Application (Biocon Pharma Inc.)

View source ↗

Summary

The FDA approved Biocon Pharma Inc.'s liraglutide original application (ANDA 217063), providing a generic version of liraglutide.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Obesity
• Type 2 Diabetes Mellitus

Drugs mentioned

• liraglutide (liraglutide)

Snippet

ORIG AP for LIRAGLUTIDE (LIRAGLUTIDE)